The North America Genetic Engineering Drug Market is experiencing robust growth due to increasing healthcare expenditure, rapid technological advancements, and expanding applications of genetic engineering in disease treatment. The region, led by the United States and Canada, is witnessing significant investments in biotechnology innovation, gene editing technologies, recombinant DNA research,...